Abiopharma

New Form 6-K - PURPLE BIOTECH LTD. Filed: 2025-10-28 AccNo: 0001213900-25-103079 Size: 583 KB

(19% Negative) Arcus Biosciences, Inc. (RCUS) Announces Clinical Trial Timeline Adjustment

(99% Neutral) InfuSystem Holdings, Inc. (INFU) Files Form 8-K

New Form 10-Q - EKSO BIONICS HOLDINGS, INC. Filed: 2025-10-28 AccNo: 0001437749-25-031960 Size: 8 MB

New Form S-8 POS - Adaptimmune Therapeutics PLC Filed: 2025-10-28 AccNo: 0001104659-25-103166 Size: 23 KB

New Form S-8 POS - Adaptimmune Therapeutics PLC Filed: 2025-10-28 AccNo: 0001104659-25-103165 Size: 23 KB

📋 Todd F watanabe (officer) plans to sell 40K shares of Arcutis Biotherapeutics Inc (at $25.03 each, total $1.0M) Filed: Oct 28, 2025 | ID: 046746

(30% Negative) OrthoPediatrics Corp. (KIDS) Reports Q4 2025 Financial Results

New Form POS AM - Adaptimmune Therapeutics PLC Filed: 2025-10-28 AccNo: 0001104659-25-103158 Size: 20 KB

(30% Negative) Ekso Bionics Holdings, Inc. (EKSO) Reports Q4 2025 Financial Results

Seymour June Ann 🟢 acquired 50.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $8.85 Transaction Date: Oct 27, 2025 | Filing ID: 000112

New Form 6-K - Galmed Pharmaceuticals Ltd. Filed: 2025-10-28 AccNo: 0001493152-25-019879 Size: 16 KB

BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors